Acne Medication Market Analysis

  • Report ID: 6417
  • Published Date: Sep 11, 2024
  • Report Format: PDF, PPT

Acne Medication Market Analysis

 Product (Antibiotics, Retinoids, Isotretinoin)

Antibiotics segment is projected to account for more than 46.5% acne medication market share by the end of 2037. According to NCBI, pharmacological drugs such as antibiotics are the first line of treatment for mild to moderate-stage acne. Antibiotics effectively kill skin bacteria and reduce inflammation surrounding the affected area and are available in two forms topical and oral, wherein clindamycin and erythromycin are widely adopted topical antibiotics, and tetracyclines and macrolide are oral ones. American Academy of Dermatology (AAD) estimates that the use of topical antibiotics alongside retinoids or benzoyl peroxide in acne treatment offers effective results.

Distribution Channel (Retail and Online Pharmacies, Hospital Pharmacies)

Sales of acne medications through retail and online pharmacies in acne medication market are anticipated to rise at a high CAGR throughout the forecast period. The easy availability of over-the-counter (OTC) medications is driving the online sales of acne drugs. Patients can easily compare and buy acne OTC medications without a prescription and a direct visit to physical stores, this convenience is contributing to their online sales growth. Retail pharmacies are also equipped with advanced and latest medications, which reduces the need to visit hospital pharmacies. Furthermore, online and retail pharmacies offer various discounts and offers, which make them the most sought-after mode of distribution channel.

Our in-depth analysis of the acne medication market includes the following segments:

Product

  • Antibiotics
  • Retinoids
  • Isotretinoin

Route of Administration

  • Topical
  • Oral

Age Group

  • 10-17 Years
  • 18-44 Years
  • 45-65 Years
  • 65 Years and Above

Distribution Channel

  • Retail and Online Pharmacies
  • Hospital Pharmacies 
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 6417
  • Published Date: Sep 11, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The global acne medication market is estimated at USD 12.7 billion in 2025.

Expanding at a CAGR of 5.4%, the global market is anticipated to increase from USD 12.1 billion in 2024 to USD 23.3 billion by 2037.

Some of the leading companies are Galderma S.A., Bausch Health Companies Inc., Teva Pharmaceutical Industries Ltd., GlaxoSmithKline Plc., and Pfizer Inc.

Antibiotics are anticipated to capture 46.5% of the global market share by 2037.

North America leads the sales of acne medications and is expected to hold the dominance through 2037 owing to the high prevalence of acne and other skin-related disorders.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample